Robert Moder possesses extensive experience in quality assurance and compliance within the biotechnology and pharmaceutical sectors. Currently serving as the Director of Quality Assurance at CARsgen Therapeutics since February 2024, Robert previously held leadership roles as Director of QA Operations at KBI Biopharma and Associate Director of Quality Systems & Compliance at Merck. At Renaissance Lakewood, LLC, Robert contributed as Senior Manager, Strategic Compliance Initiative, and in various quality assurance roles. Early career experience includes significant positions at DPT Laboratories, where Robert managed quality control testing and performed critical laboratory functions as a Biotech Scientist. Robert obtained a Master of Arts in Molecular Biology from Princeton University and dual Bachelor's degrees in Biology and Chemistry from King's College.
Previous companies
February, 2024 - present